Summary. The drug approval process consists of two stages: clinical trials (CT) and new drug application (NDA) approval. Orphan drugs are medicines or vaccines intended to treat, prevent or diagnose a rare disease. New programs in orphan drug development may offer valuable solutions to bring orphan treatments to the market more quickly in despite of hight prices. The aim of this study is to review the range and types of existing policies adopted by Europe to enable the availability and accessibility of orphan drugs.
Giannetta N., Cianciulli A., Dionisi S., Figura M., Di Simone E., Di Muzio M. (2019). Farmaci orfani: uno sguardo sulle politiche di produzione e ricerca in ambito europeo. GIORNALE ITALIANO DI FARMACIA CLINICA, 33(1), 29-34 [10.1721/3124.31053].
Farmaci orfani: uno sguardo sulle politiche di produzione e ricerca in ambito europeo
Figura M.;
2019-01-01
Abstract
Summary. The drug approval process consists of two stages: clinical trials (CT) and new drug application (NDA) approval. Orphan drugs are medicines or vaccines intended to treat, prevent or diagnose a rare disease. New programs in orphan drug development may offer valuable solutions to bring orphan treatments to the market more quickly in despite of hight prices. The aim of this study is to review the range and types of existing policies adopted by Europe to enable the availability and accessibility of orphan drugs.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Giannetta, 2019.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
180.31 kB
Formato
Adobe PDF
|
180.31 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
